Sources / A regulatory filing

23andMe Holding Co., exhibit 99.1 to Form 8-K (SEC), 30 October 2023

3 records were read from this source, dated 30 Oct 2023 to 11 Oct 2026.

Open it on sec.gov

Its permanent copy is being made in the Wayback Machine.

Last checked 19 Oct 2026

What was read from it

Records read from this source
Record	Kind	As stated	Dated
A one-year non-exclusive licence to 23andMe's genetic and health survey database, including new data and some added analyses, to GSK (after the exclusive period ended)	Price observation	a $20 million upfront payment for a one year, non-exclusive data license for a one-year…	30 Oct 2023
Price exclusivity by what it covers: sole distribution earns a little more, sole use by one buyer earns a multiple	Negotiation lever	What exclusivity is worth depends on what it covers. Where it means sole distribution…	10 Sep 2026
Exclusivity and exclusivity windows	Licence term	Offer exclusivity only for a defined field and a defined window, and charge a multiple…	11 Oct 2026

A one-year non-exclusive licence to 23andMe's genetic and health survey database, including new data and some added analyses, to GSK (after the exclusive period ended)
Kind
Price observation
As stated
a $20 million upfront payment for a one year, non-exclusive data license for a one-year…
Dated
30 Oct 2023
Price exclusivity by what it covers: sole distribution earns a little more, sole use by one buyer earns a multiple
Kind
Negotiation lever
As stated
What exclusivity is worth depends on what it covers. Where it means sole distribution…
Dated
10 Sep 2026
Exclusivity and exclusivity windows
Kind
Licence term
As stated
Offer exclusivity only for a defined field and a defined window, and charge a multiple…
Dated
11 Oct 2026

Figures it feeds

23andMe Holding Co., exhibit 99.1 to Form 8-K (SEC), 30 October 2023: what was read from… | AIData.Broker